Insider · CIK 0002081460
Esther Cho
Files at KROS (Keros Therapeutics, Inc.). First filing Feb 20, 2026, latest Feb 20, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KROS: Keros Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Keros Therapeutics, Inc. | $78k 4,745 shares | -11% | +69% from low-26% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | KROS Keros Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Feb 26, 2026 |
| Feb 18, 2026 | KROS Keros Therapeutics, Inc. | SOpen-market sale Common Stock | -4,745 | $16.35 | $78k | 39,755 | Feb 20, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.